Centene to acquire PANTHERx

 

• Centene Corporation (NYSE:CNC) has signed a definitive agreement to acquire PANTHERx, one of the largest and fastest-growing specialty pharmacies in the United States specializing in orphan drugs and rare diseases.
• PANTHERx and its management team will continue to operate independently as part of Centene's Envolve Pharmacy Solutions, a total drug management program that includes integrated Pharmacy Benefit Manager services and specialty pharmacy solutions to millions of members throughout the United States.
• The transaction is expected to close by the end of 2020.
• Financial terms of the acquisition is undisclosed.
• https://seekingalpha.com/news/3644344-centene-to-acquire-pantherx